NASDAQInformation TechnologyInformation Technology ServicesSnapshot 2026-10-15
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
Living Fair Value by QuarterlyIQ
A valuation that evolves as the business changes.
A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.
View Living FV report and workflowThree key conditions need to be met for the investment thesis to play out.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Effective management of capital and financial obligations | A primary condition in CID HOLDCO INC's published investment case. The stated target is Maintain controlled capital allocation and reduce financial risk. | Under Pressure | New large financial obligations or equity sales increase risk | Qualitative: $52.0M equity issuance (8.4M Series C Preferred) vs controlled allocation target DAIC issued 8.4M Series C Preferred and 233k Common shares worth $52.0M to BladeRanger to complete an acquisition. Context reviewed through Oct 15, 2026Last status assessment Oct 15, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 16–Oct 15 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This investment represents a turnaround situation with potential for recovery, but current performance is weak. The company is focusing on strategic alternatives and compliance, which may stabilize its position over the next few years.
The market appears to have priced in a low level of fragility, suggesting some resilience despite recent challenges. Valuation is considered cheap compared to peers, indicating that expectations may be low.
Management is actively pursuing strategic alternatives, which may improve the balance sheet and support compliance with Nasdaq listing requirements. However, recent financial performance has been weak, and there are elevated risks that could impact future results.
The thesis hinges on management's ability to execute their strategic priorities and the broader tech sector's performance. Key factors include potential rate cuts by the Fed and the performance of sector bellwethers like IBM and ACN.
In the next 1 to 3 years, DAIC's trajectory will depend on management execution and external market conditions. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Successful implementation of reverse stock split | A supporting condition in CID HOLDCO INC's published investment case. The stated target is Complete reverse stock split as planned. | Intact | Reverse split is delayed or cancelled | Qualitative condition This condition has no defined numerical measure. Context reviewed through Oct 15, 2026Last status assessment Oct 15, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue reaches about $6.75 million in 2026 | Revenue guidance targets about $6.75 million for 2026. | Intact | Revenue falls below $6 million in FY26 | Revenue: $12,398 FY2026-Q2; GAAP. Published target: ~$6.75 million. Target period is not explicitly aligned with this observation. Source published Sep 25, 202612,398 USD · source valueSource reportLast status assessment Oct 15, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: cad27440-d12f-410b-bcc0-d528205a724b. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.